{
    "symbol": "BIO",
    "quarter": 2,
    "year": 2022,
    "date": "2022-07-28 21:52:05",
    "content": "  Net sales for the second quarter of 2022 were $691.1 million, which is a 3.5% decline on a reported basis versus $715.9 million in Q2 of 2021. Sales of the Life Science Group in the second quarter of 2022 were $322.4 million, compared to $334.2 million in Q2 of 2021, which is a 3.5% decline on a reported basis and a 0.5% increase on a currency-neutral basis. Sales of the Clinical Diagnostics Group in the second quarter were $367.8 million, compared to $380.2 million in Q2 of 2021, which is a 3.3% decline on a reported basis and growth of 0.7% on a currency-neutral basis."
}